Clinical Trial Update: Study to Evaluate the Safety and Tolerability of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of CNTX-4975 for Morton's neuroma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morton Neuroma

Drugs mentioned

• CNTX-4975

Snippet

Sponsor: Centrexion Therapeutics | Conditions: Morton's Neuroma | Phase 1 | Status: COMPLETED